biomedicina slovenica


"Breast" : 2827

  1. Tomšič Sonja; Žagar Tina; Mihor Ana; Mlakar Miran; Lokar Katarina; Jarm Katja; Zadnik Vesna
    Prognostic factors and outcomes in women with breast cancer in Slovenia in relation to step-wise implementation of organized screening
    2022
  2. Zavrtanik Čelan Alenka; Prosen Mirko
    Vrnitev medicinskih sester v delovno aktivno življenje po zdravljenju raka dojk
    [Nurse's return to active work after breast cancer treatment]
    2022
  3. Twelves Chris; Bartsch Rupert; Ben-Baruch Noa Efrat; Borštnar Simona; Dirix Luc Yves; Tesarova Petra; Timcheva Constanta; Zhukova Lyudmila; Pivot Xavier
    The place of chemotherapy in the evolving treatment landscape for patients with HR-positive/HER2-negative MBC
    2022
  4. De Laurentiis Michelino; Borštnar Simona
    Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population
    2021
  5. Partridge Ann H.; Borštnar Simona
    Who are the women who enrolled in the POSITIVE trial
    2021
  6. Strojnik Ksenija; Krajc Mateja; Šetrajčič Dragoš Vita; Stegel Vida; Novaković Srdjan; Blatnik Ana
    Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk
    2021
  7. Rachev Boris; Wilking Nils; Kobelt Gisela; Spandonaro Federico; Rajer Mirjana; Roediger Alexander; Normand Raphaël; Zielinski Christoph
    Budget projections and clinical impact of an immuno-oncology class of treatments
    2021
  8. Elimova Elena; Moignard Stephanie; Li Xuan; Yu Manshu; Xu Wei; Šeruga Boštjan; Tannock Ian F.
    Updating reports of phase 3 clinical trials for cancer
    2021
  9. Ratoša Ivica; Chirilǎ Monica Emilia; Steinacher Mateja; Kozma Elvisa; Vojtíšek Radovan; Franco Pierfrancesco; Poortmans Philip
    Hypofractionated radiation therapy for breast cancer
    2021
  10. Nizič Tea; Krajc Mateja; Blatnik Ana; Stegel Vida; Škerl Petra; Novaković Srdjan; Gazić Barbara; Bešić Nikola
    Bilateral disease common among Slovenian CHEK2-positive breast cancer patients
    2021
  11. Sant Milena; Meneghini Elisabetta; Bastos Joana; Rossi Gian Paolo; Guevara Marcela; Innos Kaire; Katalinic Alexander; Majuelo Leire Gil; Marcos-Gragera Rafael; Zadnik Vesna
    Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe
    2020
  12. Kovač Anja; Matos Erika; Grašič-Kuhar Cvetka; Čakš Marina; Ovčariček Tanja; Mencinger Marina; Humar Mojca; Borštnar Simona
    Efficacy and safety of selective cyclin-dependent kinases 4/6 inhibitors in hormone-receptor-positive, HER2-negative advanced breast cancer
    2020
  13. Gligorov Joseph; Ataseven B.; Verrill M.; De Laurentiis Michelino; Jung K. H.; Azim Hatem A.; Al-Sakaff N.; Lauer S.; Shing M.; Pivot Xavier; Takač Iztok
    Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer
    2017
  14. Allemani Claudia; Matsuda Tomohiro; Di Carlo Veronica; Harewood Rhea; Matz Melissa; Nikšić Maja; Bonaventure Audrey; Valkov Mikhail; Estève Jacques; Coleman Michel P.; Primic-Žakelj Maja; Zadnik Vesna
    Global surveillance of trends in cancer survival 2000-14 (CONCORD-3)
    2018
  15. Regan Meredith M.; Škof Erik
    Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer
    2013
  16. Bernhard Jürg; Škof Erik
    Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT)
    2015
  17. Van Geloven Nan; Giardiello Daniele; Bonneville Edouard F; Teece Lucy; Ramspek Chava L; Van Smeden Maarten; Snell Kym I E; Van Calster Ben; Pohar Perme Maja
    Validation of prediction models in the presence of competing risks
    2022
  18. Redenšek Trampuž Sara; Cvetkoska Aspasija; Dolžan Vita; Marinko Tanja; Goričar Katja
    Genetic variability and expression of miR-21 and miR-34a as biomarkers of cardiotoxicity after radiotherapy in breast cancer
    2022
  19. Goričar Katja; Marinko Tanja; Dolžan Vita
    Biomarkers of radiotherapy response in breast cancer reporter genes in two murine tumor cell lines in vitro
    2022
  20. Miroševič Špela; Prins Judith B.; Borštnar Simona; Bešić Nikola; Homar Vesna; Selič-Zupančič Polona; Škufca Smrdel Andreja Cirila; Klemenc-Ketiš Zalika
    Factors associated with a high level of unmet needs and their prevalence in the breast cancer survivors 1‐5 years after post local treatment and (neo)adjuvant chemotherapy during the COVID-19
    2022
  21. Višić Uroš; Stopar Pintarič Tatjana; Blajić Iva; Albreht Tit; Lučovnik Miha
    Vpliv multimodalne analgezije na samostojnost otročnic pri osebni higieni, skrbi za novorojenčka in dojenja po carskem rezu
    [Influence of multimodal analgesia on maternal independent personal hygiene, newborn care and breastfeeding after cesarean delivery]
    2022
  22. Goričar Katja; Dugar Franja; Dolžan Vita; Marinko Tanja
    NBN, RAD51 and XRCC3 polymorphisms as potential predictive biomarkers of adjuvant radiotherapy toxicity in early HER2-positive breast cancer
    2022
  23. Madorran Eneko; Stožer Andraž; Arsov Zoran; Maver Uroš; Rožanc Jan
    A promising method for the determination of cell viability: the membrane potential cell viability assay
    2022
  24. Ratoša Ivica; Dobnikar Nika; Bottosso Michele; Dieci Maria Vittoria; Jacot William; Pouderoux Stéphane; Ribnikar Domen; Sinoquet Léa; Guarneri Valentina; Žnidarič Tanja
    Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer
    2022
  25. Blatnik Ana; Ribnikar Domen; Šetrajčič Dragoš Vita; Novaković Srdjan; Stegel Vida; Grčar-Kuzmanov Biljana; Boc Nina; Perić Barbara; Škerl Petra; Klančar Gašper; Krajc Mateja
    BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome
    2022
  26. Marmolejo David Humberto; Zheng Wong Mark Yu; Bajalica-Lagercrantz Svetlana; Tischkowitz Marc; Balmaña Judith; Balázs Patócs Attila; Colas Chrystelle; Genuardi Maurizio; Klink Barbara; Krajc Mateja
    Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe
    2021
  27. Bizjak Maruša; Pavlin Mojca; Pirkmajer Sergej
    Vpliv metformina na rakave celice v kulturi v odvisnosti od razpoložljivih hranil
    [Effects of metformin on cancer cells in vitro as a function of the available nutrients]
    2018
  28. De Boer Anna Z.; Bastiaannet Esther; Schetelig Johannes; De Glas Nienke A.; Manevski Damjan; Putter Hein; Liefers Gerrit Jan Liefers; De Munck Linda; Portielje Johanneke E.A.; Wreede Liesbeth C. de
    Breast cancer mortality of older patients with and without recurrence analysed by novel multi-state models
    2022
  29. Vella Francesca; Filetti Veronica; Cirrincione Luigi; Rapisarda Venerando; Matera Serena; Škerjanc Alenka; Cannizzaro Emanuele; Vitale Ermano
    Work ability after breast cancer
    2022
  30. Podlesnikar Tomaž; Berlot Boštjan; Dolenc Jure; Goričar Katja; Marinko Tanja
    Radiotherapy-induced cardiotoxicity
    2022
  31. Ratoša Ivica; Grašič-Kuhar Cvetka
    Stališča onkologov o bolniški odsotnosti bolnic z rakom dojk, ki so v delovnem razmerju
    [Oncologists' attitudes about sick leave in patients with breast cancer who are returning to work]
    2022
  32. Lubajnšek Nadja
    Paliativna oskrba na Oddelku za ginekološko onkologijo in onkologijo dojk Univerzitetnega kliničnega centra Maribor
    [Palliative care at the Department of Gynecologic Oncology and Breast Oncology of the University Medical Centre Maribor]
    2021
  33. Čretnik Andrej; Gavrić-Lovrec Vida
    Pretrganje prikrivanih prsnih vsadkov kot razlog za kronično sistemsko vnetno dogajanje, ki se je končalo z večorgansko odpovedjo - prikaz primera
    [Hidden breast implants rupture as a cause for chronic systemic inflammatory diseases resulting in a multiorgan failure - a case report]
    2021
  34. Kozar Nejc
    Uporaba metabolomike pri odkrivanju novih tumorskih označevalcev pri ginekoloških rakih
    [Use of metabolomics in search for new tumour markers in gynecological cancers]
    2021
  35. Arko Darja; Takač Iztok
    Hormonsko nadomestno zdravljenje in tveganje za raka dojk
    [Hormone replacement therapy and breast cancer risk]
    2021
  36. Ložar Taja; Žgajnar Janez; Perhavec Andraž; Blatnik Ana; Novaković Srdjan; Krajc Mateja
    Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia
    2021
  37. Ratoša Ivica; Skoblar Vidmar Marija
    Stereotactic radiosurgery for patients with breast cancer brain oligometastases
    2021
  38. Burja Blaž; Hočevar Alojzija; Šekoranja Daja; Živec Katarina; Rotar Žiga; Shoenfeld Yehuda; Praprotnik Sonja
    PR3-ANCA vasculitis associated with Asia syndrome following breast implantation
    2022
  39. Nemanič Tiva; Marc-Malovrh Mateja
    Uporaba trajnega drenažnega plevralnega katetra pri malignih plevralnih izlivih ‐ naše izkušnje
    [ndwelling pleural catheter for malignant pleural effusions ‐ our experience]
    2022
  40. Borštnar Simona; Palacova Marketa; Łacko Aleksandra; Timcheva Constanta; Gal-Yam Einav Nili; Papazisis Konstantinos; Beniak Juraj; Kudela Pavol; Rubovszky Gábor
    Ribociclib plus letrozole in patients with hormone receptor-positive, HER2-negative advanced breast cancer with no prior endocrine therapy
    2022
  41. Pušnik Julija; Mlinar Suzana
    Analiza samopregledovanja dojk glede na oblikovan življenjski slog žensk
    2022
  42. Imenšek Eva; Petruz Iris; Androjna Sabina; Žager Marciuš Valerija
    Primerjava obsevanja raka dojk v antero-posteriorni in postero-anteriorni smeri
    [Comparison of breast cancer irradiation in supine and prone positions]
    2022
  43. Burja Blaž; Hočevar Alojzija; Šekoranja Daja; Živec Katarina; Rotar Žiga; Shoenfeld Yehuda; Praprotnik Sonja
    PR3-ANCA vasculitis as manifestation of ASIA syndrome following aesthetic breast augmentation
    2022
  44. Sibinovska Nadica; Kristan Katja; akelj Simon
    Suitability and reliability of in vitro epithelial cell models for nasal and pulmonary drug permeability determination
    [Ustreznost in zanesljivost in vitro epitelijskih celinih modelov za doloanje nazalne in pulmonalne permeabilnosti zdravilnih uinkovin]
    2021
  45. Reen Tadeja; Rozman Damjana; Kovcs Tnde; Kovcs Patrik; Sipos Adrienn; Bai Pter; Mik Edit
    The role of bile acids in carcinogenesis
    2022
  46. Zadnik Vesna; agar Tina; Tomi Sonja; Mihor Ana; Lokar Katarina
    Cancer patients survival according to socioeconomic environment in a high-income country with universal health coverage
    2022
  47. Doboviek Luka; Novak Metka; Krstanovi Fran; Bortnar Simona; Lah Turnek Tamara; Debeljak Nataa
    Effect of combining CBD with standard breast cancer therapeutics
    2022
  48. ivec Katarina; Veber Matija; Piem Joe; Je Mojca; Boikov Kreimir; vajger Urban
    Intraoperative intradermal application of stromal vascular fraction into the abdominal suture line
    2022
  49. Sinreih Maa; Gregori Klara; Gajser Kristina; Laninik-Riner Tea
    Physiological concentrations of cimicifuga racemosa extract do not affect expression of genes involved in estrogen biosynthesis and action in endometrial and ovarian cell lines
    2022
  50. Mlakar Izidor; Tement Sara; Horvat Matej; Ravnik Maja; Flis Vojko; Smrke Urka
    Establishing an expert consensus on key indicators of the quality of life among breast cancer survivors: a modified Delphi study
    2022
  51. Veitch Zachary; Ribnikar Domen; Tilley Derek; Tang Patricia; King Karen; Bedard Philippe L.; Lupichuk Sasha; Cescon David W.
    No evidence of disease versus residual disease in long-term responders to first-line HER2-targeted therapy for metastatic breast cancer
    2022
  52. Lohmann Ana Elisa; Soldera Sara V.; Pimentel Isabel; Ribnikar Domen; Ennis Marguerite; Amir Eitan; Goodwin Pamela J.
    Association of obesity with breast cancer outcome in relation to cancer subtypes
    2021
  53. Tankova Tsvetalina; Senkus-Konefka ElCbieta; Beloyartseva Maria; Bortnar Simona; Catrinoiu Doina; Frolova Mona; Hegmane Alinta; Jane Andrej; Krni Mladen; Vrdoljak Eduard
    Management strategies for hyperglycemia associated with the ]-selective PI3K inhibitor alpelisib for the treatment of breast cancer
    2022
  54. Stegel Vida; Blatnik Ana; kof Erik; etraji Drago Vita; Krajc Mateja; Gregori Brigita; kerl Petra; Strojnik Ksenija; Klanar Gaper; Banjac Marta; gajnar Janez; Ravnik-Oblak Maja; Novakovi Srdjan
    Real-world data on detection of germline and somatic pathogenic/likely pathogenic variants in BRCA1/2 and other susceptibility genes in ovarian cancer patients using next generation sequencing
    2022
  55. Repas Jernej; Zupin Mateja; Vodlan Maja; Verani Peter; Gole Boris; Potonik Uro; Pavlin Mojca
    Dual effect of combined metformin and 2-deoxy-D-glucose treatment on mitochondrial biogenesis and PD-L1 expression in triple-negative breast cancer cells
    2022
  56. Wang Yuehan; Reulen Raoul C.; Kremer Leontien C. M.; Haupt Riccardo; Zadravec-Zaletel Lorna; Bagnasco Francesca; Demoor-Goldschmidt Charlotte; Haddy Nadia; Hjorth Lars; Kuehni Claudia E.
    Male breast cancer after childhood cancer
    2022
  57. Kozar Nejc; Kruusmaa Kristi; Bitenc Marko; Argamasilla Rosa; Adsuar Antonio; Taka Iztok; Arko Darja
    Identification of novel diagnostic biomarkers in breast cancer using targeted metabolomic profiling
    2021
  58. Pashayan Nora; Antoniou Antonis C.; Ivanu Urka; Esserman Laura; Sroczynski Gaby; Hall Per; Cuzick Jack; Evans D. Gareth; Simard Jacques; Schmutzler Rita
    Personalized early detection and prevention of breast cancer
    2020
  59. Bedenk Jure
    Stem cells in human breast milk and neonate
    2022
  60. elenik Helena Sabina; Potonik Uro
    Peripheral blood transcriptome in breast cancer patients as a source of less invasive immune biomarkers for personalized medicine, and implications for triple negative breast cancer
    2022
  61. Skok Kristijan; Gradinik Lidija; elenik Helena Sabina; Milojevi Marko; Potonik Uro; Jezernik Gregor; Gorenjak Mario; Soboan Monika; Taka Iztok; Kavalar Rajko; Maver Uro
    MFUM-BrTNBC-1, a newly established patient-derived triple-negative breast cancer cell line
    2022
  62. Privek Nina; Grai-Kuhar Cvetka
    Uinkovitost in najpogosteji neeleni uinki zdravljenja z zaviralci od ciklina odvisnih kinaz 4 in 6 (CDK 4/6) pri metastatskem raku dojke
    [Overview of the efficacy and most common side effects of treatment with cyclin-dependent kinase 4 and 6 (CDK 4/6) inhibitors in metastatic breast cancer]
    2021
  63. Meattini Icro; Becherini Charlotta; Boersma Liesbeth J.; Kaidar-Person Orit; Nader Marta Gustavo; Montero Angel; Vrou Offersen Birgitte; Aznar Marianne C.; Marinko Tanja; Ratoa Ivica
    European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer
    2022
  64. Babuder Barbara; Hotujec Simona; Blatnik Ana; Strojnik Ksenija; Banjac Marta; Novakovi Srdjan; Krajc Mateja
    Predsimptomatsko genetsko testiranje za dedni sindrom raka dojk in/ali jajnikov
    [The uptake of presymptomatic genetic testing for hereditary breast and/or ovarian cancer syndrome]
    2021
  65. Zielonke Nadine; Geuzinge Amarens; Heijnsdijk Eveline A. M.; Heinvaara Sirpa; Senore Carlo; Jarm Katja; De Koning Harry J.; Ravesteyn Nicolien T. van
    Extending age ranges in breast cancer screening in four European countries
    2021
  66. Zemlji Jokhadar pela; Kokot Gaper; Pavlin Mojca; Derganc Jure
    Adhesion and stiffness of detached breast cancer cells in vitro
    2021
  67. Renelj Andrej; Gvozdenovi Nada; emaar Maja
    MitomiRs: their roles in mitochondria and importance in cancer cell metabolism
    2021
  68. Grilc Oskar; Rogelj Klemen
    Avtologna rekonstrukcija dojk v asu covid-19 pandemije
    [Autologous breast reconstruction during covid-19 pandemic]
    2021
  69. Vii Uro; Stopar Pintari Tatjana; Albreht Tit; Blaji Iva; Luovnik Miha
    Multimodal stepwise analgesia for reducing opioid consumption after cesarean delivery
    2021
  70. Jarm Katja; Kadivec Maksimiljan; val Cveto; Hertl Kristijana; Primic-akelj Maja; Dean Peter B.; Karsa Lawrence von; gajnar Janez; Gazi Barbara; Kutnar Veronika; Zdear Urban; Kurir-Borovi Mateja; Zadnik Vesna; Josipovi Igor; Krajc Mateja
    Quality assured implementation of the Slovenian breast cancer screening programme
    2021
  71. Matos Erika; Ovariek Tanja
    Breast cancer during pregnancy
    2021
  72. Jesenko Tanja; Modic iga; Grai-Kuhar Cvetka; emaar Maja; Matkovi Urka; Miceska Simona; Varl Jerneja; Kuhar Anamarija; Kloboves-Prevodnik Veronika
    Morphological features of breast cancer circulating tumor cells in blood after physical and biological type of isolation
    2021
  73. Goriar Katja; Stojanov Konda Jakob Timotej; Marinko Tanja; Dolan Vita
    Catalase and paraoxonase 1 polymorphisms are associated with late adverse events of radiotherapy in breast cancer
    2021
  74. Lesjak Nea; Mlinar Suzana
    Samoocena znanja tudentk zdravstvene nege o raku dojk
    2019
  75. Ratoa Ivica; Plavc Gaber; Pilar Nina; agar Tina; Perhavec Andra; Franco Pierfrancesco
    Improved survival after breast-conserving therapy compared with mastectomy in stage I-IIA breast cancer
    2021
  76. korja Nives; Dolinar Klemen; Mi Katarina; Matkovi Urka; Bizjak Marua; Pavlin Mojca; Podbregar Matej; Pirkmajer Sergej
    Suppression of pyruvate dehydrogenase kinase by dichloroacetate in cancer and skeletal muscle cells is isoform specific and partially independent of HIF-1[alpha]
    2021
  77. Ratoa Ivica; But-Hadi Jasna
    Vpliv visokodozne in nizkodozne izpostavljenosti srnih struktur na srno-ilne posledice obsevanja raka dojke in raka plju
    [The impact of high and low cardiac substructure dose levels on cardiac toxicity in lung and breast cancer radiotherapy]
    2021
  78. Ribnikar Domen; Ribeiro Joana M.; Pinto David; Sousa Berta; Pinto Ana Catarina; Gomes Eva; Moser Elisabeth Charlote; Cardoso Joao Maria; Cardoso Fatima
    Breast cancer under age 40
    2015
  79. Kotnik Urka; Peterlin Borut; Lovrei Luca
    Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women guidelines
    2021
  80. Bukovec Petra; Lozar Krivec Jana
    Pomen dojenja
    [The importance of breastfeeding]
    2017
  81. Mlinar Karmen; Ropret Sandra; Debeljak Nataa
    Analysis of cannabinoid receptors in breast cancer cell lines
    2021
  82. Zupani Sanja; Kruljac Ivona; otari Mojca; Drobni Radobuljac Maja
    Adolescent with autism and gender dysphoria
    2021
  83. ehi Merima; Koler Huzjak Mirjam; Strauss Maja
    Ishrana u ranom djetinjstvu i rizik za astmu i alergijske bolesti
    [Nutrition in early life and the risk of asthma and allergic diseases]
    2021
  84. Cencelj-Arne Romi; Ahan Uro
    Rekonstruktivni posegi po operacijah raka dojk
    [Reconstructive procedures after breast cancer surgery]
    2020
  85. Piccart Martine; Van't Veer Laura; Poncet Coralie; Lopes Cardozo Josephine M N; Delaloge Suzette; Pierga Jean-Yves; Vuylsteke Peter; Brain Etienne; Vrijaldenhoven Suzan; Matos Erika
    70-gene signature as an aid for treatment decisions in early breast cancer
    2021
  86. Brumec Maa; Soboan Monika; Taka Iztok; Arko Darja
    Clinical implications of androgen-positive triple-negative breast cancer
    2021
  87. Skok Kristijan; Gradinik Lidija; Maver Uro; Kozar Nejc; Soboan Monika; Taka Iztok; Arko Darja; Kavalar Rajko
    Gynaecological cancers and their cell lines
    2021
  88. Veitch Zachary; Khan Omar F.; Tilley Derek; Tang Patricia; Ribnikar Domen; Stewart Douglas A.; Kostaras Xanthoula; King Karen; Lupichuk Sasha
    Impact of cumulative chemotherapy dose on survival with adjuvant FEC-D chemotherapy for breast cancer
    2019
  89. Soboan Monika; Turk Maja; ater Pija; as-Sikoek Nina; Crnobrnja Bojana; Taka Iztok; Arko Darja
    Clinical features and their effect on outcomes of patients with triple negative breast cancer with or without lymph node involvement
    2020
  90. Veitch Zachary; Khan Omar F.; Tilley Derek; Ribnikar Domen; Kostaras Xanthoula; King Karen; Tang Patricia; Lupichuk Sasha
    Real-world outcomes of adjuvant chemotherapy for node-negative and node-positive HER2-positive breast cancer
    2019
  91. Marinko Tanja; Stojanov Konda Jakob Timotej; Dolan Vita; Goriar Katja
    P115 - Polymorphisms in antioxidant genes as predictive factors of radiotherapy late skin adverse events in breast cancer patients
    2021
  92. Cencelj-Arne Romi; Novak Jerica; Kleviar Ivani Andreja; Bonjak Maa; emaar Maja; Snoj Marko
    Radiotherapy-associated angiosarcoma in the breast reconstructed by autologous free-flap and treated with electrochemotherapy
    2021
  93. Grai Lunar Karmen; Rotovnik-Kozjek Nada; Kova-Bla Milena
    Changes in eating habits in breast cancer patients
    [Spremembe prehranjevalnih navad pri bolnicah z rakom dojk]
    2021
  94. Marinko Tanja; Stojanov Konda Jakob Timotej; Dolan Vita; Goriar Katja
    Genetic variability of PON1 and NT-proBNP levels after breast cancer radiotherapy
    2020
  95. Marinko Tanja; Stojanov Konda Jakob Timotej; Dolan Vita; Goriar Katja
    Genetic variability of antioxidative mechanisms and cardiotoxicity after adjuvant radiotherapy in HER2-positive breast cancer patients
    2020
  96. Kastnerova Liubov; Luzar Botjan; Goto Keisuke; Grishakov Viktor; Gatalica Zoran; Kamarachev Jivko; Martinek Petr; Hjkova Veronika; Grossmann Petr; Imai Hiroshi
    Secretory carcinoma of the skin
    2019
  97. Ratoa Ivica
    Impact of the COVID-19 pandemic on patients with breast cancer receiving radiation therapy
    2020
  98. Zalokar Nika; Meki Nejc
    Efficacy of breast shielding during head computed tomography examination
    2021
  99. Jarm Katja; Hertl Kristijana; Krajc Mateja; val Cveto; Kutnar Veronika; Kurir-Borovi Mateja; Primic-akelj Maja; Zadnik Vesna; Kadivec Maksimiljan
    Deset let Dravnega presejalnega programa za raka dojk Dora
    [Ten years of the National breast cancer screening programme Dora]
    2020
  100. Lapillonne Alexandre; Bronsky Jiri; Campoy Cristina; Embleton Nicholas; Fewtrell Mary; Fidler Mis Nataa; Gerasimidis Konstantinos; Hojsak Iva; Hulst Jessie; Indrio Flavia
    Feeding the late and moderately preterm infant
    2019

1 101 201 301 401 501 601 701 801 901  



New search Comments Top of page Institute for Biostatistics and Medical Informatics